U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C9H13N
Molecular Weight 135.2062
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AMPHETAMINE

SMILES

CC(N)CC1=CC=CC=C1

InChI

InChIKey=KWTSXDURSIMDCE-UHFFFAOYSA-N
InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3

HIDE SMILES / InChI
Molecular Formula C9H13N
Molecular Weight 135.2062
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:03:20 UTC 2023
Edited
by admin
on Fri Dec 15 15:03:20 UTC 2023
Record UNII
CK833KGX7E
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AMPHETAMINE
HSDB   MI   VANDF  
Systematic Name English
SELEGILINE HYDROCHLORIDE IMPURITY B [EP IMPURITY]
Common Name English
NSC-27159
Code English
ADZENYS XR-ODT
Brand Name English
amfetamine [INN]
Common Name English
(±)-.ALPHA.-METHYLPHENETHYLAMINE
Systematic Name English
NOREPHEDRANE
Common Name English
AMFETAMIN
Brand Name English
AMFETAMINE [MART.]
Common Name English
1-PHENYL-2-AMINOPROPANE
Systematic Name English
.BETA.-AMINOPROPYLBENZENE
Systematic Name English
BENZENEETHANAMINE, .ALPHA.-METHYL-, (±)-
Systematic Name English
DYANAVEL
Brand Name English
AMPHETAMINE [VANDF]
Common Name English
AMFETAMINE
INN   MART.   WHO-DD  
INN  
Official Name English
Amfetamine [WHO-DD]
Common Name English
AMPHETAMINE, DL-
Common Name English
AMPHETAMINE [ORANGE BOOK]
Common Name English
MYDAYIS (MIXED SALTS OF A SINGLE ENTITY)
Brand Name English
ADZENYS ER
Brand Name English
AMPHETAMINE [HSDB]
Common Name English
AMPHETAMINE [MI]
Common Name English
(±)-DESOXYNOREPHEDRINE
Common Name English
Classification Tree Code System Code
CFR 21 CFR 250.101
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
LIVERTOX 50
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
NDF-RT N0000175729
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
WHO-VATC QN06BA01
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
NCI_THESAURUS C47795
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
DEA NO. 1100
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
WHO-ATC N06BA01
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
CFR 21 CFR 862.3100
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
FDA ORPHAN DRUG 405313
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
DEA NO. 7401
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
NDF-RT N0000175739
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
CFR 21 CFR 310.502
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
Code System Code Type Description
NCI_THESAURUS
C62006
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY
NSC
27159
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY
DRUG CENTRAL
195
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY
CAS
300-62-9
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY
EPA CompTox
DTXSID4022600
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY
MESH
D000661
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY
CHEBI
2679
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY
HSDB
3287
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY
WIKIPEDIA
AMPHETAMINE
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY
MERCK INDEX
m1849
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY Merck Index
DRUG BANK
DB00182
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY
IUPHAR
4804
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY
PUBCHEM
3007
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY
LACTMED
Amphetamine
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY
INN
377
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY
DAILYMED
CK833KGX7E
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY
EVMPD
SUB05418MIG
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY
ECHA (EC/EINECS)
206-096-2
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY
FDA UNII
CK833KGX7E
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY
INCB IDS CODE
PA 003
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY
SMS_ID
100000087217
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY
ChEMBL
CHEMBL405
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY
RXCUI
725
Created by admin on Fri Dec 15 15:03:20 UTC 2023 , Edited by admin on Fri Dec 15 15:03:20 UTC 2023
PRIMARY RxNorm
Related Record Type Details
MULTIDRUG AND TOXIN EXTRUSION PROTEIN 1
TRANSPORTER -> SUBSTRATE
Structure of AMPHETAMINE SULFATE
SALT/SOLVATE -> PARENT
TRACE AMINE-ASSOCIATED RECEPTOR 1
TARGET -> AGONIST
Structure of Amphetamine hydrochloride
SALT/SOLVATE -> PARENT
Structure of AMPHETAMINE ASPARTATE
SALT/SOLVATE -> PARENT
AMINE OXIDASE (FLAVIN-CONTAINING) B
METABOLIC ENZYME -> INHIBITOR
Structure of AMPHETAMINE ADIPATE
SALT/SOLVATE -> PARENT
PLASMA PROTEIN FRACTION (HUMAN)
BINDER->LIGAND
BINDING
Structure of AMPHETAMINE TARTRATE
SALT/SOLVATE -> PARENT
Structure of AMPHETAMINE PHOSPHATE
SALT/SOLVATE -> PARENT
MATE-2
TRANSPORTER -> SUBSTRATE
Structure of AMPHETAMINE CHLORPHENOXYACETATE
SALT/SOLVATE -> PARENT
OCT-2
TRANSPORTER -> SUBSTRATE
TRACE AMINE-ASSOCIATED RECEPTOR 1
TARGET -> AGONIST
Related Record Type Details
Structure of PHENYLPROPANOLAMINE
METABOLITE ACTIVE -> PARENT
Structure of PHENYLACETYLCARBINOL, (±)-
METABOLITE -> PARENT
Structure of PHENYLACETIC ACID
METABOLITE -> PARENT
Structure of METHAMPHETAMINE
PARENT -> METABOLITE
Structure of BENZOYL GLUCURONIDE
METABOLITE -> PARENT
Structure of HYDROXYAMPHETAMINE
METABOLITE ACTIVE -> PARENT
Structure of Benzoic acid
METABOLITE -> PARENT
Structure of PHENYLACETONE
METABOLITE -> PARENT
Structure of HIPPURIC ACID
METABOLITE -> PARENT
Structure of N-HYDROXYAMPHETAMINE
METABOLITE -> PARENT
Structure of FENETHYLLINE
PARENT -> METABOLITE ACTIVE
MAJOR
URINE
Structure of P-HYDROXYNOREPHEDRINE
METABOLITE -> PARENT
Related Record Type Details
Structure of SELEGILINE HYDROCHLORIDE
PARENT -> IMPURITY
UNSPECIFIED
EP
Structure of FORMETOREX
IMPURITY -> PARENT
Structure of MAPA
IMPURITY -> PARENT
Structure of PHENYLPROPANOLAMINE
IMPURITY -> PARENT
Structure of APAA
IMPURITY -> PARENT
Structure of APAAN
IMPURITY -> PARENT
Structure of BENZALDEHYDE
IMPURITY -> PARENT
Related Record Type Details
Structure of AMPHETAMINE
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Volume of Distribution PHARMACOKINETIC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966